Information concerning longitudinal cognitive trajectories in multiple sclerosis (MS) is relatively scarce. Moreover, it is unclear which factors are associated with cognitive decline and what is the clinical impact of cognitive impairment (CI) in the long run.
Objective:
To investigate cognitive trajectories in relapsing–remitting multiple sclerosis (RRMS) patients, analyzing clinical and magnetic resonance imaging (MRI) predictors of cognitive decline.
Methods:
We enrolled 42 patients and 30 controls. They underwent brain MRI and clinical/neuropsychological evaluation at baseline and after 1, 2, and 6 years. We evaluated cognitive domains with principal component analysis and performed multivariable regression analyzing predictors of clinical/cognitive deterioration. We also performed repeated measures analysis to assess whether clinical progression was different according to CI at baseline.
Results:
A total of 23 (62.2%) patients deteriorated in combined cognitive domains after 6 years, most in processing speed and memory. The number of baseline impaired cognitive domains was strongly associated with 6-year cognitive (R2 = 0.452; p < 0.001) and Expanded Disability Status Scale (EDSS) deterioration (R2 = 0.263; p < 0.001). Patients with baseline CI in combined domains had worse clinical progression.
Conclusion:
Isolated CI tends to become more widespread, affecting memory and processing speed alongside. The extent of baseline CI was the best predictor of both clinical and cognitive deterioration after 6 years.
SumowskiJFBenedictREnzingerC, et al. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology2018; 90(6): 278–288. doi: 10.1212/WNL.0000000000004977
2.
PlancheVGibelinMCregutD, et al. Cognitive impairment in a population-based study of patients with multiple sclerosis: Differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis. Eur J Neurol2016; 23(2): 282–289. doi: 10.1111/ene.12715
3.
EijlersAJCvan GeestQDekkerI, et al. Predicting cognitive decline in multiple sclerosis: A 5-year follow-up study. Brain2018; 141(9): 2605–2618. doi: 10.1093/brain/awy202
4.
ZivadinovRSepcicJNasuelliD, et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry2001; 70(6): 773–780. doi: 10.1136/jnnp.70.6.773
5.
AmatoMPPortaccioEGorettiB, et al. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol2007; 64(8): 1157–1161. doi: 10.1001/archneur.64.8.1157
6.
AmatoMPPonzianiGSiracusaG, et al. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch Neurol2001; 58(10): 1602–1606. doi: 10.1001/archneur.58.10.1602
RoccaMARiccitelliGCMeaniA, et al. Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study. Mult Scler2019; 25: 372–381.
9.
RaoSMLeoGJBernardinL, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology1991; 41: 685–691.
10.
AmatoMPPonzianiGPracucciG, et al. Cognitive impairment in early-onset multiple sclerosis. Arch Neurol1995; 52(2): 168–172. doi: 10.1001/archneur.1995.00540260072019
11.
KujalaPPortinRRuutiainenJ.The progress of cognitive decline in multiple sclerosis: A controlled 3-year follow-up. Brain1997; 120(Pt. 2): 289–297.
12.
DeloireMRuetAHamelD, et al. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult Scler2010; 16(5): 581–587. doi: 10.1177/1352458510362819
13.
MocciaMLanzilloRPalladinoR, et al. Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression. Mult Scler2016; 22(5): 659–667. doi: 10.1177/1352458515599075
14.
PitteriMRomualdiCMagliozziR, et al. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study. Mult Scler2017; 23(6): 848–854. doi: 10.1177/1352458516665496
15.
DamascenoADamascenoBPCendesF.Subclinical MRI disease activity influences cognitive performance in MS patients. Mult Scler Relat Disord2015; 4(2): 137–143. doi: 10.1016/j.msard.2015.01.006
16.
DamascenoADamascenoBPCendesF.No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy. Mult Scler2016; 22(1): 64–72. doi: 10.1177/1352458515604383
17.
RudickRACutterGReingoldS.The multiple sclerosis functional composite: A new clinical outcome measure for multiple sderosis trials. Mult Scler2002; 8(5): 359–365. doi: 10.1191/1352458502ms845oa
18.
KruppLBLaRoccaNGMuir-NashJ, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989; 46: 1121–1123.
19.
ZungWW.A self-rating depression scale. Arch Gen Psychiatry1965; 12: 63–70.
20.
DamascenoAAmaral BarreiraAABeckerJ, et al. Normative values of the Brief Repeatable Battery of Neuropsychological Tests in a Brazilian population sample: Discrete and regression-based norms. Arq Neuropsiquiatr2018; 76(3): 163–169. doi: 10.1590/0004-282x20180006
21.
AttixDKStoryTJCheluneGJ, et al. The prediction of change: Normative neuropsychological trajectories. Clin Neuropsychol2009; 23(1): 21–38. doi: 10.1080/13854040801945078
22.
PortaccioEGorettiBZipoliV, et al. Reliability, practice effects, and change indices for Rao’s brief repeatable battery. Mult Scler2010; 16: 611–617.
23.
GeurtsJJRoosendaalSDCalabreseM, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology2011; 76(5): 418–424. doi: 10.1212/WNL.0b013e31820a0cc4
24.
DaleAMFischlBSerenoMI.Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage1999; 9(2): 179–194.
25.
FischlBSerenoMIDaleAM.Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage1999; 9(2): 195–207.
26.
ReuterMSchmanskyNJRosasHD, et al. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage2012; 61(4): 1402–1418.
27.
DeloireMSRuetAHamelD, et al. MRI predictors of cognitive outcome in early multiple sclerosis. Neurology2011; 76(13): 1161–1167. doi: 10.1212/WNL.0b013e318212a8be
28.
RuanoLPortaccioEGorettiB, et al. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler2017; 23(9): 1258–1267. doi: 10.1177/1352458516674367
29.
BenedictRHRamasamyDMunschauerF, et al. Memory impairment in multiple sclerosis: Correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry2009; 80(2): 201–206. doi: 10.1136/jnnp.2008.148403
30.
CalabreseMPorettoVFavarettoA, et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain2012; 135(Pt. 10): 2952–2961. doi: 10.1093/brain/aws246
31.
Schmitzer-TorbertNCRedishAD.Task-dependent encoding of space and events by striatal neurons is dependent on neural subtype. Neuroscience2008; 153(2): 349–360. doi: 10.1016/j.neuroscience.2008.01.081
32.
RoccaMABarkhofFDe LucaJ, et al. The hippocampus in multiple sclerosis. Lancet Neurol2018; 17: 918–926. doi: 10.1016/S1474-4422(18)30309
33.
Glikmann-JohnstonYOrenNHendlerT, et al. Distinct functional connectivity of the hippocampus during semantic and phonemic fluency. Neuropsychologia2015; 69: 39–49. doi: 10.1016/j.neuropsychologia.2015.01.031
34.
SarazinMSternYBerrC, et al. Neuropsychological predictors of dependency in patients with Alzheimer disease. Neurology2005; 64(6): 1027–1031.
35.
AlbertMSMossMBTanziR, et al. Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc2001; 7(5): 631–639.
